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Epidermal cells in vitro produce and deposit fibronectin 
(FN) in the pericellular m atrix . Such FN production by 
epidermal cells m ay be involved in vivo in w ound reepi-
thelialization , tissue morphogenesis, and growth of epi-
thelial tumors. The purpose of this study w as to examine 
whether the FN, previously shown to be within and sur-
rounding human basal cell carcinoma (Bee) lobules, was 
in part the product of epidermal-derived tumor cells . T o 
examine this q~lestion w e took advantage of our ability to 
grow human Bee in nude mice. Since w e could dem-
onstrate that all stromal cells surrounding the Bee were 
of mouse origin, antibodies specific for human FN would 
distinguish epithelial-derived FN from m esenchymal-
derived FN. Five solid Bees were implanted subcutane-
ously in nude mice. Growing tumors w ere removed after 
60 days, snap-frozen, sectioned on a cryostat, and verified 
microscopically as Bee. The Hoescht DNA stain, which 
can distinguish mouse and human nuclei, demonstrated 
that mouse, not human, fibroblasts occupied the stroma 
B asal cell carcino mas (Be e) are common skin cancers. T he relationship o f the tumor cells of the Bee to the surrounding stroma may be an important fea ture in the grow th o f Bee. Recent studies have demon-strated that Bees are surrounded by a basement 
membrane zone (BMZ) at the periphery of the tumor, which, 
like the BMZ of the normal epidermis, contains bullous pem-
phigoid (BP) antigen , type IV collagen , laminin (LM) , fibron ectin 
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surrounding each tumor lobule. Sections o f all 5 Bees 
were stained by imml{nofluorescence and immunoperox-
idase techniques with antibodies to bullous pemphigoid 
(BP) antigen, laminin (LM) , and FN . BP antigen and LM 
w ere present at the basem ent m embrane zone (BMZ) o f 
all tumor lobules as previously described for in situ Bee. 
FN staining w as present along the BMZ, within the tumor 
lobules, and in the surrounding stroma. Antibodies to hu-
m an FN w ere passed over a mouse FN affinity column to 
absorb antibodies which cross-reacted with mouse FN. The 
resultant antibody preparation, which was specific for hu-
m an FN in this sys tem , continued to dem onstrate FN along 
the BMZ and within the tumo rs , but failed to stain FN in 
more distant stroma. Epidermal-derived cell s, therefore, 
can synthesize and deposit FN in vivo in adj acent extra-
cellular matrix . We speculate that this FN m atrix may fa-
cilitate growth of Bee in this model. ] Invest Dennatol 
87: 42-46, 1986 
(FN), and type V collagen [1-6]. However, unlike the normal 
epidermal BMZ, the area surrounding Bee shows a discontin-
uous pattern with bullous pemphigoid (BP) antibodies [2], in-
dica tin g fewer hemidesmosomes [7-9], and a bright continuous 
pattern with anti-FN antibodies . Fib ronectin has been noted not 
only at the tumor periphery but also in the stro ma and w ithin 
the tumor substance itself [4,6] . Since FN appea rs to be an im-
portant, if not essential, matrix protein for the migratin g epithelial 
tongue during wound healing [1 0-12] , it may be an important 
component of slowly expansile ca rcino mas, such as Bee. O ur 
previous study demonstrated indirect evidence that the FN m ay 
in part be the product of the tumo r cells of Bee [6]. 
In this study, we present direct evidence that FN disposed along 
the tumor-stro mal interface and among tumo r cells is, at least in 
part, derived from the epithelioid tumor cells. This investigation 
takes advantage of the successful implantation of Bee into nude 
mice [1 3]. Since we demonstrated that all stromal cells surround_ 
ing the Bee were of mouse origin, antibodies specific for human 
FN would provide a means to distin guish epitheli al-derived FN 
from mesenchymal-derived FN. In fac t, FN antibodies, adsorbed 
with mouse FN , and therefore specific for human FN in thi 
system , demonstrated that human FN was present along the tu-
mor-stromal interface and among tumor cells. In addition , this 
study demonstrated that Bee retains the morphology and base-
ment membrane immunopathology characteristics of the original 
tumor. 
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MA TERIALS AND METHODS 
Basal Cell Carcinoma Tissue Tissue was obtained from 5 
patients with biopsy-proved BCC, who were undergoing Mohs' 
controlled excision . The tumors were transplanted into splenec-
tomized athymic nude mice that were further immunosuppressed 
with antilymphocyte serum (MA Bioproducts, Walkerville, 
Maryland). The details of this technique have been previously 
described [13] . 
Tissue Harvesting The growing BCC were removed 60 days 
after implantation, fro zen in OCT comp<;llInd, and sectioned on 
a cryostat into 4-,um sections. The presence of BCC in those 
sections was verified microscopically with a modified hematoxy-
lin and eosin technique. 
DNA Stain Cultured nude mouse skin and human foreskin 
fibroblasts , nude mouse and human epidermis , and BCC tissue 
implanted and grown in the nude mouse were stained with a 
Hoescht DNA kit (Flow Laboratories, McLean, Virginia). The 
3 types of specimens were ai r dried, fixed in Carnoy's fixative (1 
part glacial acetic acid, 3 parts absolute methanol) for 15 min on 
glass slides, and placed in the Hoescht's stain for 30 min at the 
concentration supplied by Flow Laboratories . The specimens were 
removed from the stain, placed in distilled water for three 1-min 
washes, and then coverslipped with mounting media supplied in 
the kit. The specimens w ere viewed with an Olympus epi-illu-
minating microscope containing an HBO-I00 mercury light source 
and a filter pack for the fluorochrome, bis-benzimide-h-3 ,3,2, 5,8-
trihydrochloride penta hydrate (L 405-420, Y 455) (Olympus di-
chroic mirror assembly UV excitation BH2-DMUV). In all cases 
mouse nuclei could be distin guished from human nuclei. 
Antibodies Antihuman FN antibodies were elicited by im-
munizing rabbits with purified human FN [14] and isolated by 
DEAE chromatography and NH4S04 precipitation as previously 
described [15] . These antibodies reacted to FN, not type I, III, 
or IV coHagen nor LM, by inhibition enzyme-linked immuno-
sorbent assay (ELISA) . Normal human plasma was examined by 
immunoblot technique after sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-P AGE) with these antibodies 
and only demonstrated a doublet band at 220 kD, the character-
istic area for plas ma FN. In addition, these antibodies show char-
acteristic staining patterns for FN when used to examine normal 
human skin by immunofluorescence techniques. Thus these an-
tibodies have been shown to be specific for FN by multiple tech-
niques. Anti-FN antibodies were passed over a mouse FN affinity 
column to adsorb the antibody sub population that cross-reacted 
with mouse FN. Mouse FN for the affinity column was purified 
from the serum of nude mice by adsorption to gela tin-Sepharose 
4B [16] . The eluted nude mouse FN was then conjugated to 
activated Sepharose 4B (Pharmacia, Piscataway, N ew Jersey) to 
produce an affinity SlIbstrate . 
Antilaminin antibodies were elicited by immunizing a sheep 
with purified mouse LM [17] (Bethesda Research Laboratories, 
Bethesda, Maryland) and isolated by DEAE chromatography and 
NH4S04 precipitation. BP antiserum was obtained from a patient 
w ho had high titer of circulating antibodies (1: 1000). Antikeratin 
antibodies were kindly provided by T .-T. Sun [18] or purchased 
from DAKO Laboratories (Santa Barbara, California) . 
Immunofluorescence Tissue sections of the 5 BCC grown in 
nude mice were stained for BP, LM, and FN. All tissue sections 
for these studies were air dried , then washed in phosphate-buff-
ered saline (PBS) , pH 7.4, 3 times for 15 min each time. Direct 
and indirect immunofluorescence techniques are described for each 
antisera used in this study. 
An avidin-biotin immunofluorescent technique was utilized to 
stain with adsorbed and nonadsorbed anti-FN antibodies. This 
technique employed 4-,um tissue sections of BCC tumor grown 
in the nude mice and of mouse skin . Adjacent sections were 
stained for 1 h with either a 1: 500 dilution of rabbit antihuman 
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FN which cross-reacted with mouse FN or a 1: 500 dilution of 
adsorbed rabbit antihuman FN w hich was specific for human FN . 
The sections were washed 3 times in PBS, incubated with 5 ,ug/ml 
biotinylated goat anti rabbit IgG (Vector Laboratories, Inc.) for 
30 min , washed 3 times, and then stained w ith 20 ,ug/ml fluo-
rescein isothiocyanate avidin (Vector Laboratories, Inc.). T he 
specimens were again washed in PBS and mounted with a recently 
described mountiHi medium containing paraphenylenediamine 
which retards fluorescein quenching [1 9]. 
A 1: 100 dilution of flu orescein-conjugated sheep antilaminin 
was prepared in filtered PBS, pH 7.4. The tumor sections were 
incubated with antibody solution for 1 h, washed in PBS 3 times, 
acetone fixed, then covered with mounting medium as described 
in the previous paragraph. The specimens were reviewed with 
an Olympus epi-illumination microscope containing an HBO-
100 mercury light source and a filter pack for fluorescein (BP 
450-490, FT 510, LB 520). 
Indirect immunofluorescence was performed to detect the pres-
ence of BP antigen. BP antiserum was diluted 1 : 10 with ftltered 
PBS, pH 7.4, and placed on the sections in the incubation chamber 
for 30 min. The specimen was washed in PBS 3 times and then 
incubated with the second antibody, a fluorescein-conjugated rab-
bit antihuman IgG (Calbiochem-Behring Corporation), for 1 h. 
The tissue was again washed in PBS 3 times, acetone fixed, and 
covered with mounting medium as previously described. An 
avidin-biotin immunoperoxidase technique was also utilized to 
stain transplanted tumor tissue with antikeratin antibodies . 
RESULTS 
Light Microscopy of Frozen BCC Specimens Histologic 
sections of frozen tissue stained with the modified hematoxylin 
and eosin technique gave good morphologic detail consistent with 
nodular BCC in each case. The initial tumor morphology before 
transplantation was maintained after transplantation [13] . 
Hoescht Stain Fig lA demonstrates a culture of mouse fibro-
blas ts stained with the Hoescht stain in which the nuclei stain in 
a bright parti culate pattern . In contrast, human fibroblasts stained 
with the Hoescht stain do not demonstrate the bright particulate 
nuclear pattern (Fig IE) . Mouse epidermal nuclei in skin sections 
also stain with a bright particulate pattern, Similar t? cultured 
mouse fibroblasts, while human epidermal nuclei 111 sk111 sections 
show a diffuse staining pattern, similar to cultured l~uman fibro-
blasts (Fig 2). Thus, the Hoescht stain can dlst111gUlsh morpho-
Figure 1. Cultured mouse (A) and human (8) fibroblasts stained with 
the Hoescht DNA stain. Fibroblasts were grown from explants of nude 
mouse skin and human neonatal foreskin in MEM with 10% fetal calf 
serum. At equivalent passages mouse and human fibroblasts were plated 
in Lab-Tee chambers, grown to confluence, fixed and stained. Original 
magnifica tion X 400. 
44 GRIM WOOD ET AL 
Fig ure 2. Norma l mouse epidermis (A) and norm al hum an epidermis 
(B) stained with Hoescht DNA sta in. 
logica ll y mouse cell s from hum an cells w hether in cu lture or in 
tissue sections. Fig 3 shows a ti ss ue specim en taken from a human 
BCC transplantat ion site in the nude m ouse at 60 da ys and stain ed 
w ith the I-l oescht sta in . The BCC tum or lobule in the upper 
portion of the fi gure is clea rl y di stinct from the spindle ceUs th at 
surround th e tum or lo bule. T he tum o r cell nuclei show a dull , 
diffuse stainin g pattern character ist ic of human nuclei w hile th e 
spindle cell s in the surroundin g strom a have a bright, particulate 
pattern character isti c of mouse nucl ei. In additi on, the cells w ithin 
the tumor m ass were shown to be epithelial cells, no t fibroblas ts, 
by their positi ve sta ining for keratin (data not shown). 
Antilaminin and Anti-BP Immunofluorescence Im-
mun oflu o rescence sta inin g w ith these antibodi es was carried out 
fo r each sampled tum o r. T here was positi ve staining for both 
LM and BP in all cases . The LM dem onstrated a continuous linea r 
pattern sur round ing th e tumor lobules (Fig 4B) while the BP 
antibody stained th e periphery of th e tumor lobules in a discon-
tinuous pattern (Fig 4A). T hi s d ifference between LM and BP 
antigen stainin g patterns occurred in all sa mpled tum ors. 
Adsorbed and Nonadsorbed Anti-FN Immunofluores-
cence Fig 5A represents no rm al mouse skin sta ined w ith the 
nonadsorbed antihuman FN w hi ch cross-reacted w ith mouse FN 
and demonstrated positive staining in the dermis, wh ile Fig 5B 
represents normal mouse skin s tained w ith the adsorbed anti-
Figure 3. B C lobule, stained with the Hocscht stain, 60 days after 
transplantation into the subcutaneous tissue of a nude mouse. The ce ll 
nuclei of the tumor lobule sta in with a weak diffuse pattern while strom al 
spindle ce lls (probably fibrob lasts) stain with a bright particulate pattern . 
Original magnifica tion X 200. 
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Figure 4. Bee stained with anti-BP antiserum (A) and anti-LM anti-
bodies (B) 60 days after transplantation into a nude mouse. Original 
magn ifica tion X 200. 
human FN and shows no specific stainin g in the dermis. Fig 6 
delTlOnstrates adj acent tissue sections taken from a transpl anted 
human BCC harvested from the nude mouse at 60 days. In panel 
A, the BCC tiss ue was stained with nonadsorbed anti-FN anti, 
body that reacts with both human and mouse FN and there is 
pos itive staining in the peripheral stroma , along the tumor m ar, 
g ins, and in ent rapped stroma in the superio r portion of the tu_ 
mor. T his pattern of staining is similar to th at reported in OUr 
previous studies [6]. Panel B illustrates a section of adj acent tumor 
tissue stained with adsorbed anti-FN antiserum that reacts only 
with human FN. There is positive stainin g in close proximity to 
the tumor cells but no staining in the strom a. This findin g was 
consistent in all 5 mice studied. 
DI SCU SSIO N 
T he development of a nude mouse system for the transplantatio~ 
and propagation of human BCC [13] in v ivo has g iven us a unigue 
opportunity to inves tigate w hether epider mal-derived tumor cell 
deposit FN in the extracellular matrix at the tumor-stroma in, 
terface and within the tumor lobules [4,6]. The immunofluores, 
cence studies in this paper have demonstrated that BP antigcl\ 
and laminill were present at the BMZ of all human BCC growl\ 
in the nude mouse (Fig 4) and that FN was present along th 
BMZ, within the tumor lobules, and in the surrounding strom~ 
(Fig 6A). These results indica te that the extracellular matrix w ithil\ 
and around BCC grown in nude mice is similar to the matrix in 
situ [6], thus indicating that th e source ofFN at the BMZ in thi 
system probably reflects the so urce of tumor BMZ FN in situ. 
Since the main strategy of this study was to identify w hethet 
human epithelial-derived FN occurred in the BMZ and amon~ 
tumor cells by anti-FN antibodies specific for human FN, w~ 
first needed to demonstrate that only human epithelial cells, anq 
not strom al cells, w ere implanted into nude mice. In our searc~ 
for methods to acco mplish this task, w e found th at the Hoesch\ 
DNA stain [20-22] could differenti ate human and mouse cells o~ 
the ?ases of staining patterns: m ouse nucl ei stained with a brigh\ 
particulate pattern (FIgs l A, 2A) while human nuclei stained dif, 
fu sely (Figs 1B, 2B). Utilizing this staining technigue we dem, 
onstrated that the BCC were, indeed, human in origin and thaI 
all cells (fibroblasts) in the surrounding stroma were of mous~ 
origin (Fig 3). 
T hese mouse fibrobl as ts are a ~otential source of FN [23,24) 
at the tumor BMZ as well as wlthm the stroma. In addition, 
mouse plasma FN mi ght be deposited within and around th\ 
tumor and in the stroma [10,25]. T he human epitheli al tumol 
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Figure 5. N o rm al nude mouse skin sta ined w ith nonadsorbcd antihu man FN antibodies (A) and with antihuman FN antibod ies aftcr passage over a 
m o usc FN affini ty column (8) . Original magnification X 200. 
cells are ano ther potential source of tumor-stromal interface FN 
as well as intralobular FN since human keratinocytes have been 
demonstrated to synthesize, secrete, and deposit FN in the peri-
cellular matrix in vit ro [15 ,26,27]. Thus, human FN might derive 
from the Bee cell s while mouse FN might derive either from 
fibroblasts o r plas m a. To determine whether epithelioid cells con-
tribute FN to the extracellular matrix in vivo we prepared anti-
FN an tibodies that were specific for hum an FN in this system by 
passing antihuman FN an tibodies over a mouse FN affinity col-
umn to adsorb antibodies that cross-reacted with mouse FN (Fig 
5). As show n in Fig 6, an tihuman FN antibodies that cross-reacted 
w ith mouse FN demonstrated FN along the BMZ, within the 
tumor lobules, and in the surrounding stroma (pa /l el A) while 
antihuman FN antibod ies preadsorbed on a mouse FN affinity 
column continued to demonstrate FN along the BMZ and within 
the tumor lobules but not in the surrounding stroma (panel B) . 
These results are taken to illustrate that the FN at the tumor BMZ 
and within the tumor lobules is at leas t in part derived from the 
human epithelioid tumor cells. To our knowledge this is the first 
evidence that ep ithelial cells can deposit FN in the extracellular 
matrix in vivo. 
Although FN is not normally present within the intact epi-
dermis, it is present along the normal epidermal-derm al BMZ 
[28- 30]. H owever, in certain situations such as skin morpho-
genesis [31, 32], disease sta tes that disrupt the normal epidermal-
dermal interface [33,34], reepithelialization of a cutaneous wound 
[35,36J, and epidermal-derived tumor growth [4,6], FN not on ly 
marked ly increases along the BMZ of the epidermal-dermal in-
terface but also occurs at times within the epidermis. Although 
we have previously demonstrated, in a rat-mouse xenograft sys-
tem using species-specific reciprocal antibodies, that th e FN at 
the BMZ of th e migrating epidermis in a healing wound was 
partially in situ derived we could not distinguish epioermal-de-
rived FN from fibrob last-derived FN in this system since the 
wound was made in a fu ll-thi ckness rat sk in graft transplanted 
on thymectomized, antilymphocyte serum-treated mi ce l1 0]. Thus, 
both epidermal cells and fibrob lasts were of rat origin while plasma 
was of mouse o ri gin . T herefo re, th is is the first evidence that 
epithelial cells ca n deposit FN at the BMZ in certain circum-
stances. A recent stud y demonstrated· that litt.l e or no FN was 
deposited in the BMZ by mouse kidney epitheli al cells during 
kidney morphogenesis [37J. The authors conclude, "A ll experi-
ments presented here suggest th at fibronectin is not synthesized 
by glomerul ar epithelial cells in vivo." O ur study, coupled with 
this previous repo rt, demonstrates the importance of not making 
generaliza tions from the outcome of one li ne of investigation. 
From these studies, we are left with the notion that under certa in , 
but not all circumstances, epi thelial cell s ca n deposit FN in the 
extracellular matrix. 
Our present stud y does not address whether mouse fibrob lasts 
also contribute to the BMZ FN. We ass ume in fac t that mouse 
fibrob lasts in the present model do contribute to the BMZ FN, 
Figure 6. Basal cell ca rcinoma, 60 days after implantation into a nude mouse, stained w ith nonadsorbcd antihuman FN antibodies (A) and with 
antihum an FN antibodies afte r passage .ovcr a mouse FN affin ity column (8). O rig inal magnifi ca tion X 200. 
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since under situations that induce granulation tissue formation 
and by extrapolation any neostromal formation, fibroblasts produce 
great quantities of FN [38,39J. 
We conclude that stromal FN probably derives from both mouse 
plasma and in situ mouse fibroblast production. The tumor nod-
ule fibronectin derives from in situ human basaloid tumor cell 
production. We speculate that as FN appears to be important for 
optimal epithelial regrowth after skin [llJ and corneal [12J in-
juries, FN produced by BCC cells may facilitate tumor growth 
and expansion . 
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